Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?

por Lewis-Wambi, Joan S, Jordan, V Craig
Publicado 2009

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

por Hayes, Erin L, Lewis-Wambi, Joan S
Publicado 2015

Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer

por Provance, Olivia K., Lewis-Wambi, Joan
Publicado 2019

Retraction Note: Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

por Jan, Rifat, Huang, Min, Lewis-Wambi, Joan
Publicado 2023

Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer

por Jan, Rifat, Huang, Min, Lewis-Wambi, Joan
Publicado 2012

By looking back we can see the way forward: enhancing the gains achieved with antihormone therapy

por Jordan, V Craig, Patel, Roshani, Lewis-Wambi, Joan S, Swaby, Ramona F
Publicado 2008

Everolimus downregulates estrogen receptor and induces autophagy in aromatase inhibitor-resistant breast cancer cells

por Lui, Asona, New, Jacob, Ogony, Joshua, Thomas, Sufi, Lewis-Wambi, Joan
Publicado 2016

Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator...

por Ogony, Joshua, Choi, Hye Joung, Lui, Asona, Cristofanilli, Massimo, Lewis-Wambi, Joan
Publicado 2016

Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death

por Choi, Hye Joung, Lui, Asona, Ogony, Joshua, Jan, Rifat, Sims, Peter J, Lewis-Wambi, Joan
Publicado 2015

Enhanced IFNα Signaling Promotes Ligand-Independent Activation of ERα to Promote Aromatase Inhibitor Resistance in Breast Cancer

por Escher, Taylor E., Dandawate, Prasad, Sayed, Afreen, Hagan, Christy R., Anant, Shrikant, Lewis-Wambi, Joan
Publicado 2021

Oestrogen is bad for patients with breast cancer?

por Jordan, V Craig, Ariazi, Eric A, Lewis-Wambi, Joan S, Swaby, Ramona R, Cunliffe, Heather E, Riegel, Anna T, Wellstein, Anton
Publicado 2007

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

por Lewis-Wambi, Joan S, Kim, Helen R, Wambi, Chris, Patel, Roshani, Pyle, Jennifer R, Klein-Szanto, Andres J, Jordan, V Craig
Publicado 2008

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis

por Lewis-Wambi, Joan S., Kim, Helen R., Wambi, Chris, Patel, Roshani, Pyle, Jennifer R., Klein-Szanto, Andres J., Craig Jordan, V.
Publicado 2018